Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Lilly tightens its deals and accelerates its share buyout to bolster its Inflammatory Pipeline
13 January 2026

Lilly tightens its deals and accelerates its share buyout to bolster its Inflammatory Pipeline

Introduction Eli Lilly is a person who named its pharmaceutical firm with the same name and shone for its high-quality medicines. Since 1876, Eli’s long-term vision and urge to introduce science-based healing brought the company close to success. Today, it's working on oncology, immunology an...

Parabilis Medicines’ million-dollar help to upgrade the Cancer Drug space
13 January 2026

Parabilis Medicines’ million-dollar help to upgrade the Cancer Drug space

Introduction Parabilis Medicines, formerly FogPharma, is a well-established clinical-level biopharma company passionate about developing effective peptide therapeutics known as Helicons. Helicon is like a weapon to protect undruggable cancer targets and fight all odds that disrupt focus. Parabilis ...

Protara completes first patient dosing, taking one step ahead in its THRIVE-3 Trial
12 January 2026

Protara completes first patient dosing, taking one step ahead in its THRIVE-3 Trial

Introduction Protara Therapeutics, Inc. is a leading clinical-level biopharmaceutical company that has worked wonders in establishing life-changing, effective therapies for rare diseases and cancer. The company also conducted some major programs that brought awareness and development in certain cru...

ABS’s buyout of Cureline’s excellence to bolster biopharma drug discovery
12 January 2026

ABS’s buyout of Cureline’s excellence to bolster biopharma drug discovery

Introduction ABS Bio, since its establishment in 1990, has delivered the best-in-class critical scientific relevant services involving tissue processing, cell culture, human biospecimens, biostorage and cell line engineering. This contributed a lot to biotech and pharmaceutical companies building a...

Jazz shows progress in stomach cancer with its promising findings
12 January 2026

Jazz shows progress in stomach cancer with its promising findings

Introduction Jazz Pharmaceuticals, an Ireland-based company famous for its ‘Ziihera’ (zanidatamab), which is a prescription-based medicine have been serving a total of 75 countries with its comprehensive products. With the robust pipeline and products travelling across countries and ear...

Crinetics bets a million relying on its new Phase 2 results
12 January 2026

Crinetics bets a million relying on its new Phase 2 results

Introduction Crinetics Pharmaceuticals is popular for discovering new medicines for curing endocrine-based diseases. The company came into force in 2008 with its regional origin in San Diego, California. The founders of the company, Frank Zhu, Scott Struthers, Stephen F. Betz and Ana Kusnetzow, sta...

Novoron secured funding from NIH/NIA SBIR for its Alzheimer’s Drug Discovery
09 January 2026

Novoron secured funding from NIH/NIA SBIR for its Alzheimer’s Drug Discovery

Announcement Novoron Bioscience, a well-known biotechnology company in San Diego since 2014, has been establishing new therapies for neurological injury and neurodegenerative diseases, and has now earned worth $2.5 million reward from the National Institute on Aging at the National Institutes of He...

Brain Cancer Study took one step with its first patient participation
09 January 2026

Brain Cancer Study took one step with its first patient participation

Announcement Exvade Bioscience is a certified neuro-oncology company known for its impeccable platform for healing the violent brain cancers has conducted a brain cancer study. The phase 1 clinical trial (study) has finally met its first patient. The trial is conducted at a well-known Academic Medi...

Arrowhead put the weight on Tirzepatide to help the obese population
09 January 2026

Arrowhead put the weight on Tirzepatide to help the obese population

Announcement Arrowhead is headed to double the Tirzepatide’s weightloss in the combinational study. After proving its excellence in therapies to cure the diseases causing genes, the company has now entered the obesity area with the weight of responsibility to bring best in class solution to t...

Huntington's disease in the progressive limelight
09 January 2026

Huntington's disease in the progressive limelight

Progress so far For many decades, there have been many challenges and a level of improvement in numerous neurodegenerative conditions. Over the past two years, uniQure’s data received a green signal for therapies shaping a new future for a subtype of amyotrophic lateral sclerosis (ALS) and Al...